3H-10000

· 3H Pharmaceuticals Co., Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for 3H-10000, covering 2026-01-21 to 2026-01-21. Get the full timeline:

Most recent: Clinical Trial Update: A First-in-human Study of 3H-10000 in Patients With Unresectable or Metastatic Solid Tumors [Phase 1, Phase 2]